NCT06738654 Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer.
| NCT ID | NCT06738654 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xu Yan |
| Condition | Invasive Breast Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-12-31 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2024-12-31 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate the safety,feasibility and quality of life(QoL)of single-port robotic surgery in breast-conserving surgery, compare and analyze the advantages and disadvantages of single-port robotic surgery and open surgery in terms of complications, postoperative complications, perioperative recovery effects, and safety in breast cancer breast-conserving surgery, in order to select a more effective and safe surgical method. Subjects who meet the inclusion criteria will enter the research process, with surgery including SPr-breast-conserving surgery or open-breast-conserving surgery, and the choice of the two surgical methods is based on the patient's financial situation and the availability of equipment;
Eligibility Criteria
Inclusion Criteria: 1. The patient himself has very high requirements for beauty, and requires no scar on the chest; 2. No chest surgery and radiotherapy. 3. No contraindications to surgery and anesthesia. 4. Clinical I, stage of early breast cancer and the breast has an appropriate volume, can maintain a good breast shape after surgery. 5. Patients in the clinical period who meet the standard of breast conservation surgery after preoperative treatment. 6. Age: ≥18 years old. Exclusion Criteria: 1. Inflammatory breast cancer. 2. The tumor is extensive and it's difficult to achieve negative margins or an ideal breast - conserving appearance. 3. Diffusely distributed malignant - characteristic calcifications. 4. The margin is positive after local extensive tumor resection, and a negative margin in pathological examination still can't be ensured after re - resection. 5. The patient refuses.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06738654 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Invasive Breast Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06738654 currently recruiting?
Yes, NCT06738654 is actively recruiting participants. Contact the research team at xy931@163.com for enrollment information.
Where is the NCT06738654 trial being conducted?
This trial is being conducted at Chongqing, China, Chongqing, China.
Who is sponsoring the NCT06738654 clinical trial?
NCT06738654 is sponsored by Xu Yan. The trial plans to enroll 64 participants.